Published in Int J Psychophysiol on June 04, 2010
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia. Schizophr Res (2012) 1.03
The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol (2014) 0.96
Unseen Affective Faces Influence Person Perception Judgments in Schizophrenia. Clin Psychol Sci (2014) 0.80
A Review of Anticipatory Pleasure in Schizophrenia. Curr Behav Neurosci Rep (2016) 0.79
Trait Anticipatory Pleasure Predicts Effort Expenditure for Reward. PLoS One (2015) 0.77
Trait and state positive emotional experience in schizophrenia: a meta-analysis. PLoS One (2012) 0.77
The electrophysiological signature of motivational salience in mice and implications for schizophrenia. Neuropsychopharmacology (2012) 0.77
Response preparation and intra-individual reaction time variability in schizophrenia. Acta Med Litu (2016) 0.75
The contingent negative variation in remitted paediatric bipolar patients: no evidence of abnormality. Psychiatry Investig (2013) 0.75
Motivational engagement in Parkinson's disease: Preparation for motivated action. Int J Psychophysiol (2015) 0.75
Distinct patterns of dysfunctional appetitive and aversive motivation in bipolar disorder versus schizophrenia: An event-related potential study. J Abnorm Psychol (2016) 0.75
A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology (1986) 6.17
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res (2005) 5.78
Scales for physical and social anhedonia. J Abnorm Psychol (1976) 4.31
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res (2007) 3.79
Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage (2005) 3.48
The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull (2005) 3.36
Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull (2008) 2.90
Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophr Bull (2008) 2.75
Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull (2005) 2.65
Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull (1986) 2.29
Brain potentials associated with expected and unexpected good and bad outcomes. Psychophysiology (2005) 2.28
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl) (2006) 2.23
Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. J Abnorm Psychol (2007) 2.08
It's worse than you thought: the feedback negativity and violations of reward prediction in gambling tasks. Psychophysiology (2007) 2.04
Probing picture perception: activation and emotion. Psychophysiology (1996) 1.78
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl) (2007) 1.49
Psychomotor slowing in schizophrenia. Schizophr Bull (2006) 1.36
Electrophysiological correlates of emotional responding in schizophrenia. J Abnorm Psychol (2010) 1.16
Cognitive event-related potential correlates of schizophrenia. Psychol Bull (1986) 1.02
Switching between univalent task-sets in schizophrenia: ERP evidence of an anticipatory task-set reconfiguration deficit. Clin Neurophysiol (2006) 0.97
Impaired modulation of the saccadic contingent negative variation preceding antisaccades in schizophrenia. Biol Psychiatry (2000) 0.94
Stimulus-preceding negativity induced by fear: a manifestation of affective anticipation. Int J Psychophysiol (2001) 0.93
Stimulus-Preceding Negativity and heart rate changes in anticipation of affective pictures. Int J Psychophysiol (2007) 0.93
Effects of information and reward on stimulus-preceding negativity prior to feedback stimuli. Psychophysiology (2003) 0.91
Anterior cingulate dysfunction during choice anticipation in schizophrenia. Psychiatry Res (2004) 0.90
Role of anticipation in schizophrenia-related pursuit initiation deficits. J Neurophysiol (2005) 0.89
Effect of positive and negative emotion on stimulus-preceding negativity prior to feedback stimuli. Psychophysiology (2001) 0.89
The role of the right anterior insular cortex in the right hemisphere preponderance of stimulus-preceding negativity (SPN): an fMRI study. Neurosci Lett (2008) 0.89
Effects of reward and stimulus modality on stimulus-preceding negativity. Psychophysiology (2004) 0.88
Is a stimulus conveying task-relevant information a sufficient condition to elicit a stimulus-preceding negativity? Psychophysiology (1994) 0.86
Psychophysiological evidence for impaired reward anticipation in Parkinson's disease. Clin Neurophysiol (2006) 0.86
Brain potentials indicate poor preparation for action in schizophrenia. Psychophysiology (2006) 0.85
Effects of nicotine and smoking on event-related potentials: a review. Nicotine Tob Res (2004) 0.84
Foresight in schizophrenia: a potentially unique and relevant factor to functional disability. Psychiatr Serv (2008) 0.82
Emotion and psychopathology: a startle probe analysis. Prog Exp Pers Psychopathol Res (1993) 0.82
Impairment of willed actions and use of advance information for movement preparation in schizophrenia. J Neurol Neurosurg Psychiatry (1999) 0.81
The effect of stimulus discriminability on stimulus-preceding negativities prior to instructive and feedback stimuli. Biol Psychol (1999) 0.81
Physical anhedonia and future psychopathology: an electrocortical continuity? Psychophysiology (1982) 0.80
Anticipation and response set: cortical, cardiac, and electrodermal correlates. Psychophysiology (1979) 0.79
Anticipatory pleasure deficit in subjects reporting physical anhedonia: slow cortical evidence. Biol Psychol (1982) 0.79
Heart rate, contingent negative variation, and evoked potentials during anticipation of affective stimulation. Psychophysiology (1980) 0.79
Slow cortical potentials in subjects with high or low scores on questionnaire measuring physical anhedonia and body image distortion. Psychophysiology (1981) 0.78
Motor and nonmotor event-related potentials during a complex processing task. Psychophysiology (2000) 0.77
EEG and slow brain potentials during anticipation and control of painful stimulation. Electroencephalogr Clin Neurophysiol (1982) 0.76
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry (2007) 5.64
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull (2005) 4.66
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res (2007) 3.79
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology (2006) 2.70
Biosocial pathways to functional outcome in schizophrenia. Schizophr Res (2005) 2.65
Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull (2005) 2.65
Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull (2008) 2.59
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53
The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull (2006) 2.53
Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry (2006) 2.42
The feedback-related negativity reflects the binary evaluation of good versus bad outcomes. Biol Psychol (2005) 2.33
Brain potentials associated with expected and unexpected good and bad outcomes. Psychophysiology (2005) 2.28
Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. JAMA Psychiatry (2013) 2.24
Upward spirals of positive emotions counter downward spirals of negativity: insights from the broaden-and-build theory and affective neuroscience on the treatment of emotion dysfunctions and deficits in psychopathology. Clin Psychol Rev (2010) 2.22
On the ERN and the significance of errors. Psychophysiology (2005) 2.22
To err is autonomic: error-related brain potentials, ANS activity, and post-error compensatory behavior. Psychophysiology (2003) 2.18
Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia. Am J Psychiatry (2011) 2.11
Nonconscious and conscious color priming in schizophrenia. J Psychiatr Res (2012) 2.08
Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr Bull (2010) 2.07
The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry (2013) 2.04
It's worse than you thought: the feedback negativity and violations of reward prediction in gambling tasks. Psychophysiology (2007) 2.04
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
Anxiety and error-related brain activity. Biol Psychol (2003) 1.90
Is emotion processing a predictor of functional outcome in schizophrenia? Schizophr Bull (2003) 1.89
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Intentional modulation of emotional responding to unpleasant pictures: an ERP study. Psychophysiology (2006) 1.83
Error-related psychophysiology and negative affect. Brain Cogn (2004) 1.83
Affective traits in schizophrenia and schizotypy. Schizophr Bull (2008) 1.81
Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res (2006) 1.80
Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophr Bull (2011) 1.77
Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr Res (2011) 1.73
Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry (2004) 1.72
Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol (2006) 1.71
From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry (2012) 1.68
Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res (2006) 1.67
The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res (2004) 1.59
Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull (2011) 1.56
Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophr Res (2005) 1.54
How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr Bull (2007) 1.53
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull (2008) 1.52
Psychosocial treatments to promote functional recovery in schizophrenia. Schizophr Bull (2009) 1.52
Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophr Res (2010) 1.50
Attending to affect: appraisal strategies modulate the electrocortical response to arousing pictures. Emotion (2006) 1.45
Error-related brain activity in obsessive-compulsive undergraduates. Psychiatry Res (2002) 1.45
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res (2010) 1.43
Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophr Res (2008) 1.41
Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull (2011) 1.38
The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? Schizophr Bull (2010) 1.36
Observational, physiological, and self-report measures of children's anger: relations to reactive versus proactive aggression. Child Dev (2002) 1.35
The expression and experience of emotion in schizophrenia: a study of social interactions. Psychiatry Res (2003) 1.35
Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry (2004) 1.33
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry (2007) 1.32
Increased error-related brain activity in pediatric obsessive-compulsive disorder before and after treatment. Am J Psychiatry (2007) 1.30
Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia. J Psychiatr Res (2009) 1.30
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Social perception and early visual processing in schizophrenia. Schizophr Res (2003) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophr Res (2004) 1.27
Anticipatory and consummatory components of the experience of pleasure in schizophrenia: cross-cultural validation and extension. Psychiatry Res (2009) 1.27
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol Psychiatry (2011) 1.26
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull (2003) 1.24
Modulations of the electrophysiological response to pleasant stimuli by cognitive reappraisal. Emotion (2008) 1.22
Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr Res (2010) 1.21
Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res (2011) 1.20
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res (2011) 1.17
Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res (2013) 1.16
Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry (2010) 1.16
Electrophysiological correlates of emotional responding in schizophrenia. J Abnorm Psychol (2010) 1.16
The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophr Res (2010) 1.15
Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. Am J Psychiatry (2013) 1.15
Emotional intelligence in schizophrenia. Schizophr Res (2008) 1.15
Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia? Schizophr Res (2005) 1.15
NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res (2004) 1.14
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology (2007) 1.13
The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine. Psychopharmacology (Berl) (2006) 1.13
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Event-related gamma activity in schizophrenia patients during a visual backward-masking task. Am J Psychiatry (2005) 1.11
Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophr Res (2013) 1.09
Sex differences in the time course of emotion. Emotion (2007) 1.09
Electrophysiological correlates of decreasing and increasing emotional responses to unpleasant pictures. Psychophysiology (2008) 1.08